Shares in Dexcom (NSDQ:DXCM) soared today after the medical device maker topped expectations on Wall Street with its third quarter results.
The San Diego, Calif.-based company posted a net loss of -$2 million, or -2¢ per share, on sales of $184.6 million for the 3 months ended Sept. 30, for sales growth of 24% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.